Page 83 - GPD-3-4
P. 83

Gene & Protein in Disease                                    Interleukins-1β, interleukin-8, and the SARS-CoV-2



            24.  Moreira RS. Latent class analysis of COVID-19 symptoms in   comorbidities. Res Soc Dev. 2020;9:e1299108285.
               Brazil: Results of the PNAD-COVID19 survey. Cad Saúde      doi: 10.33448/rsd-v9i10.8285
               Pública. 2021;37:14.
                                                               30.  Tang D, Comish P, Kang R. The hallmarks of COVID-19
               doi: 10.1590/0102-311x00238420                     disease. PLoS Pathog. 2020;16(5):e1008536.
            25.  Butatã I.  Não Vacinados Representam 75% das Mortes      doi: 10.1371/journal.ppat.1008536
               por Covid-19, Diz Estudo Brasileiro. São Paulo: Instituto
               Butantan; 2022.                                 31.  Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the
                                                                  cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-260.
            26.  Martins WA, de Oliveira GMM, Brandão AA, et al. Vaccinating
               patients with heart disease against COVID-19: The reasons      doi: 10.1038/s41569-020-0360-5
               for priority. Arq Bras Cardiol. 2021;116(2):213-218.  32.  Figueira K. COVID-19 em pacientes com câncer: COVID-
               doi: 10.36660/abc.20210012                         19 in cancer patients: Managing a pandemic within a
                                                                  pandemic. Braz J Implantol Health Sci. 2020;2:6.
            27.  Orellana JDY, Cunha GMd, Leite LMdC, Domingues CMA,
               Horta  BL.  Changes  in  the  pattern  of  COVID-19      doi: 10.36557/2674-8169.2020v2n12p01-06
               hospitalizations and deaths after substantial vaccination of   33.  De Sousa EL, Gaído SB, de Sousa RA,  et al. Profile of
               the elderly in Manaus, Amazonas State, Brazil. Cad Saúde   hospital admissions and deaths due to severe acute
               Pública. 2022;38:PT192321.                         respiratory syndrome caused by COVID-19 in Piauí, Brazil:
               doi: 10.1590/0102-311XPT192321                     A descriptive study, 2020-2021.  Epidemiol Serv Saúde.
                                                                  2022;31:e2021836.
            28.  Barbosa AV, da Silva SM, da Silva FH, de Assunção MAS,
               dos Anjos FBR. Características clínicas da COVID-19. In:      doi: 10.1590/s1679-49742022000100009
               Latin  American Publicações,  editor.  Fatores de Virulência   34.  Ranzani OT, Bastos LSL, Gelli JBM, et al. Characterisation
               Microbianos e Terapias Emergentes. Vol.  3. São José dos   of the first 250,000 hospital admissions for COVID-19 in
               Pinhais: Latin American Publicações; 2022. p. 355.  Brazil: A retrospective analysis of nationwide data. Lancet
                                                                  Respir Med. 2021;9(4):407-418.
            29.  Das Mercês SO, Lima FLO, de Vasconcellos Neto JRT.
               Association of COVID-19 with: Age and medical      doi: 10.1016/S2213-2600(20)30560-9











































            Volume 3 Issue 4 (2024)                         9                               doi: 10.36922/gpd.4076
   78   79   80   81   82   83   84   85   86   87   88